IL6 and intestinal disorder: This is in line with observations that dietary gangliosides can interrupt pro-inflammatory signalling via IL-1β in the intestinal mucosa, specifically suppressing production of IL-1β, NO, PGE2, hydrogen peroxide, IL-6 and IL-8, and subsequently alleviating symptoms of intestinal disease [18,74].